id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-325755-n7vjjw9r	Rai, Deependra Kumar	Post covid 19 pulmonary fibrosis- Is it real threat?	2020-11-10		.txt	text/plain	2520	140	49	This review addressed underlying mechanism, Risk factors, course of disease and treatment option for post covid pulmonary fibrosis. One of the risk factors for the development of lung fibrosis in COVID-19 is advanced age and this finding is same as in MERS and SARS-CoV. The follow-up of 36 MERS patients for average 43 days showed that lung fibrosis developed in a significant number of convalescents, and risk was found highest with patient who were elderly, hospitalised with severe disease in ICU 19 . Nintedanib use associated with increase the risk of bleeding as most of the covid 19 patient are on anticoagulant Evidence is also coming for use of pirfenidone, azithromycin and prednisolone in the management of pulmonary fibrosis post-H1N1 ARDS, based on data from a case report of three patients 25 . Elderly patient, severe disease who require ICU care and mechanical ventilation are highest risk to develop lung fibrosis	./cache/cord-325755-n7vjjw9r.txt	./txt/cord-325755-n7vjjw9r.txt